MEDDPICC LTD


Directors	BRAMBLE, Paul
	CARROLL, Jack
	LEE, Harry William
	LUTON, Bradley Howard
	MURPHY, Dean Edward
	MURRAY, Ross Alexander
	SALES, Daniel Marc


Registered Address	1 Gemini Court, 42a Throwley Way
	Sutton
	SM1 4AF


Registered Number	13454213 (England and Wales)

Statement of Financial Position
31 March 2026

	Notes	2026		2025
		£	£	£	£
Fixed assets
Investments	3		3,736,122		3,736,122
			3,736,122		3,736,122
Current assets
Cash at bank and on hand		71		110,481
		71		110,481
Creditors amounts falling due within one year	4	(3,111,364)		(3,244,320)
Net current assets (liabilities)			(3,111,293)		(3,133,839)
Total assets less current liabilities			624,829		602,283
Net assets			624,829		602,283
Capital and reserves
Called up share capital			6,012		6,000
Share premium			594,000		594,000
Profit and loss account			24,817		2,283
Shareholders' funds			624,829		602,283

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 18 June 2026, and are signed on its behalf by:

LUTON, Bradley Howard
Director
Registered Company No. 13454213

MEDDPICC LTD

Notes to the Financial Statements
for the year ended 31 March 2026

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Functional and presentation currency
	The financial statements are presented in sterling and this is the functional currency of the company.

	Turnover policy
	Turnover represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the value of the consideration due.

	Current taxation
	Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

Investments

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Cash and cash equivalents
	Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.

Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

	Trade and other creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Financial instruments
	A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment.

Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. 

	Share capital
	Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

	Related parties
	For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.

2.	Average number of employees


		2026		2025
	Average number of employees during the year	7		7

3.	Fixed asset investments

	Other investments¹	Total
	£	£
Cost or valuation
At 01 April 25	3,736,122	3,736,122
At 31 March 26	3,736,122	3,736,122
Net book value
At 31 March 26	3,736,122	3,736,122
At 31 March 25	3,736,122	3,736,122

	Notes
	¹Other investments other than loans

4.	Creditors: amounts due within one year

	2026	2025
	£	£
Bank borrowings and overdrafts	-	290,625
Taxation and social security	7,468	4,248
Other creditors	3,103,896	2,949,447
Total	3,111,364	3,244,320


	At the balance sheet date, included in other creditors an amount of £2,949,945 (2025: £2,774,518 ) was owed to Cavey Dale Group Ltd, a subsidiary which is 100% owned by the company. The loan is interest free and repayable on demand. At the balance sheet date, included in creditors within one year, an amount of £Nil (2025: £290,625) was owed to Santander UK PLC. The amount was repayable by a quarterly capital repayment of £96,875 with a marginal interest rate of 4.15%.The amount was fully repaid in the year.

At the balance sheet date, included in other creditors an amount of £2,949,945 (2025: £2,774,518 ) was owed to Cavey Dale Group Ltd, a subsidiary which is 100% owned by the company. The loan is interest free and repayable on demand.

At the balance sheet date, included in creditors within one year, an amount of  £Nil (2025: £290,625) was owed to Santander UK PLC. The amount was repayable by a quarterly capital repayment of £96,875 with a marginal interest rate of 4.15%.The amount was fully repaid in the year.

5.	Share capital
	During the year, 12 ordinary alphabet shares at £1 each were issued.

6.	Related party transactions
	During the year, management fees of £45,000 (2025: £80,000) were received from Cavey Dale Group Ltd, a subsidiary which is 100% owned by the company.

7.	Further information regarding the company's financial position
	The company's liabilities to Santander UK PLC are secured by way of fixed and floating charges on the company's assets.